BridgeBio Pharma Inc
BBIOHealthcare|Biotechnology|USA
$85.81
-4.28 (-4.75%)
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (188)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cook Jennifer E. | Director | 2026-06-24 | SELL | 39,363 | $69.92 | $2752.3K |
| Valantine Hannah | Director | 2026-06-23 | SELL | 5,004 | $68.25 | $341.5K |
| Cook Jennifer E. | Director | 2026-06-15 | SELL | 90,240 | $66.62 | $6011.8K |
| Kumar Neil | CEO | 2026-06-05 | SELL | 80,000 | $67.67 | $5413.6K |
| Kumar Neil | CEO | 2026-05-21 | SELL | 26,103 | $69.44 | $1812.6K |
| Trimarchi Thomas | President and CFO | 2026-05-18 | SELL | 13,651 | $65.08 | $888.4K |
| Scott Randal W. | Director | 2026-05-15 | SELL | 10,000 | $67.15 | $671.5K |
| Kumar Neil | CEO | 2026-05-08 | SELL | 80,000 | $67.4 | $5392K |
| Apuli Maricel | Chief Accounting Officer | 2026-04-30 | SELL | 2,000 | $71.58 | $143.2K |
| Kumar Neil | CEO | 2026-04-10 | SELL | 80,000 | $74.61 | $5968.8K |
| Kumar Neil | CEO | 2026-03-13 | SELL | 80,000 | $68.76 | $5500.8K |
| Valantine Hannah | Director | 2026-03-10 | SELL | 8,671 | $72 | $624.3K |
| Ellis Andrea | Director | 2026-03-04 | SELL | 64,921 | $64.87 | $4211.4K |
| Valantine Hannah | Director | 2026-02-27 | SELL | 25,484 | $67.41 | $1717.9K |
| Apuli Maricel | Chief Accounting Officer | 2026-02-26 | SELL | 2,000 | $66 | $132K |
| Kumar Neil | CEO | 2026-02-19 | SELL | 28,053 | $71.39 | $2002.7K |
| Trimarchi Thomas | President and CFO | 2026-02-17 | SELL | 13,600 | $74.72 | $1016.2K |
| Apuli Maricel | Chief Accounting Officer | 2026-02-17 | SELL | 510 | $74.31 | $37.9K |
| Scott Randal W. | Director | 2026-02-17 | SELL | 10,000 | $75.46 | $754.6K |
| Kumar Neil | CEO | 2026-02-11 | SELL | 80,000 | $71.86 | $5748.8K |
| Kumar Neil | CEO | 2026-01-09 | SELL | 80,000 | $75.54 | $6043.2K |
| Kumar Neil | CEO | 2025-12-15 | SELL | 30,011 | $74.64 | $2240K |
| Apuli Maricel | Chief Accounting Officer | 2025-12-08 | SELL | 2,000 | $74.26 | $148.5K |
| Kumar Neil | CEO | 2025-12-05 | SELL | 80,000 | $73.86 | $5908.8K |
| Kumar Neil | CEO | 2025-11-20 | SELL | 26,156 | $65.84 | $1722.1K |
| Lo Andrew | Director | 2025-11-18 | SELL | 95,599 | $66.11 | $6320K |
| Trimarchi Thomas | President and CFO | 2025-11-17 | SELL | 16,934 | $66.46 | $1125.4K |
| Scott Randal W. | Director | 2025-11-17 | SELL | 10,000 | $66.65 | $666.5K |
| Valantine Hannah | Director | 2025-11-12 | SELL | 25,484 | $66.07 | $1683.7K |
| Kumar Neil | CEO | 2025-11-07 | SELL | 80,000 | $62.29 | $4983.2K |
| DANIELS RONALD J | Director | 2025-11-06 | SELL | 61,031 | $63.72 | $3888.9K |
| MCCORMICK FRANK | Director | 2025-10-29 | SELL | 198,359 | $66.58 | $13206.7K |
| MCCORMICK FRANK | Director | 2025-10-27 | SELL | 1,641 | $65 | $106.7K |
| Kumar Neil | CEO | 2025-10-09 | SELL | 80,000 | $54.79 | $4383.2K |
| MCCORMICK FRANK | Director | 2025-09-05 | SELL | 74,000 | $53.16 | $3933.8K |
| Kumar Neil | CEO | 2025-09-05 | SELL | 80,000 | $52.2 | $4176K |
| Trimarchi Thomas | President and CFO | 2025-08-21 | SELL | 42,237 | $49.48 | $2089.9K |
| Kumar Neil | CEO | 2025-08-20 | SELL | 26,156 | $48.82 | $1276.9K |
| Trimarchi Thomas | President and CFO | 2025-08-18 | SELL | 17,353 | $50.23 | $871.6K |
| HOMCY CHARLES J | Director | 2025-08-11 | SELL | 300,000 | $46.37 | $13911K |
| Kumar Neil | CEO | 2025-08-08 | SELL | 80,000 | $45.84 | $3667.2K |
| Apuli Maricel | Chief Accounting Officer | 2025-08-07 | SELL | 1,000 | $45.44 | $45.4K |
| Ellis Andrea | Director | 2025-08-05 | SELL | 17,167 | $49 | $841.2K |
| Kumar Neil | CEO | 2025-07-02 | SELL | 80,000 | $42.63 | $3410.4K |
| VIKING GLOBAL INVESTORS LP | 10% Owner | 2025-06-27 | SELL | 3,500,000 | $44 | $154000K |
| Valantine Hannah | Director | 2025-06-26 | SELL | 4,707 | $44.05 | $207.3K |
| MCCORMICK FRANK | Director | 2025-06-24 | SELL | 100,000 | $44.23 | $4423K |
| Valantine Hannah | Director | 2025-06-10 | SELL | 4,292 | $40 | $171.7K |
| Kumar Neil | CEO | 2025-05-20 | SELL | 101,156 | $33.38 | $3376.6K |
| KKR Genetic Disorder L.P. | 10% Owner | 2025-05-12 | SELL | 6,000,000 | $34.2 | $205200K |
| Apuli Maricel | Chief Accounting Officer | 2025-05-02 | SELL | 1,026 | $38.51 | $39.5K |
| Lo Andrew | Director | 2025-05-02 | SELL | 100,000 | $38.5 | $3850K |
| Kumar Neil | CEO | 2025-04-22 | SELL | 75,000 | $34.11 | $2558.3K |
| Ellis Andrea | Director | 2025-04-14 | SELL | 10,000 | $35 | $350K |
| Ellis Andrea | Director | 2025-04-01 | SELL | 30,000 | $34.05 | $1021.5K |
| Kumar Neil | CEO | 2025-03-25 | SELL | 75,000 | $36.87 | $2765.3K |
| Valantine Hannah | Director | 2025-03-06 | SELL | 12,875 | $32.58 | $419.5K |
| KKR Genetic Disorder L.P. | 10% Owner | 2025-03-05 | SELL | 6,000,000 | $32.96 | $197760K |
| STEPHENSON BRIAN C | CFO and Treasurer | 2025-02-25 | SELL | 8,500 | $33.19 | $282.1K |
| Kumar Neil | CEO | 2025-02-25 | SELL | 75,000 | $33.57 | $2517.8K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2025-02-19 | SELL | 4,148 | $36.16 | $150K |
| Kumar Neil | CEO | 2025-02-19 | SELL | 31,543 | $36.14 | $1140K |
| VIKING GLOBAL INVESTORS LP | 10% Owner | 2025-01-31 | SELL | 3,065,616 | $34.9 | $106990K |
| Kumar Neil | CEO | 2025-01-29 | SELL | 600,000 | $36.31 | $21786K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2025-01-28 | SELL | 68,000 | $36.29 | $2467.7K |
| Kumar Neil | CEO | 2024-11-19 | SELL | 27,389 | $22.41 | $613.8K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2024-11-19 | SELL | 4,156 | $22.41 | $93.1K |
| KKR Genetic Disorder L.P. | 10% Owner | 2024-09-13 | SELL | 5,800,000 | $25.75 | $149350K |
| Kumar Neil | CEO | 2024-08-19 | SELL | 27,389 | $24.69 | $676.2K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2024-08-19 | SELL | 4,155 | $24.69 | $102.6K |
| Scott Randal W. | Director | 2024-06-04 | SELL | 2,500 | $30.32 | $75.8K |
| Scott Randal W. | Director | 2024-03-01 | SELL | 2,500 | $34 | $85K |
| Valantine Hannah | Director | 2024-01-16 | SELL | 2,915 | $37.97 | $110.7K |
| MCCORMICK FRANK | Director | 2023-12-26 | SELL | 100,000 | $42.06 | $4206K |
| Scott Randal W. | Director | 2023-12-18 | SELL | 2,000 | $40 | $80K |
| Valantine Hannah | Director | 2023-12-15 | SELL | 2,915 | $36.12 | $105.3K |
| Scott Randal W. | Director | 2023-12-01 | SELL | 2,500 | $29.4 | $73.5K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-11-17 | SELL | 22,685 | $29.1 | $660.1K |
| Kumar Neil | CEO and President | 2023-11-17 | SELL | 51,552 | $29.1 | $1500.2K |
| Valantine Hannah | Director | 2023-11-15 | SELL | 2,915 | $30 | $87.5K |
| Scott Randal W. | Director | 2023-09-05 | SELL | 2,500 | $30 | $75K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-08-17 | SELL | 22,683 | $28.59 | $648.5K |
| Kumar Neil | CEO and President | 2023-08-17 | SELL | 51,552 | $28.59 | $1473.9K |
| VIKING GLOBAL INVESTORS LP | 10% Owner | 2023-07-18 | SELL | 1,500,000 | $35 | $52500K |
| Kumar Neil | CEO and President | 2023-05-17 | SELL | 51,552 | $14.01 | $722.2K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-05-17 | SELL | 24,424 | $14.01 | $342.2K |
| Kumar Neil | CEO and President | 2023-05-03 | SELL | 120,000 | $14.18 | $1701.6K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-05-03 | SELL | 64,929 | $14.18 | $920.7K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-04-05 | SELL | 55,500 | $15.45 | $857.5K |
| Kumar Neil | CEO and President | 2023-04-05 | SELL | 120,000 | $15.46 | $1855.2K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-03-03 | SELL | 62,692 | $10.96 | $687.1K |
| Kumar Neil | CEO and President | 2023-03-03 | SELL | 120,000 | $10.96 | $1315.2K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-02-17 | SELL | 17,717 | $12.7 | $225K |
| Kumar Neil | CEO and President | 2023-02-17 | SELL | 44,798 | $12.7 | $568.9K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-02-03 | SELL | 61,040 | $11.01 | $672.1K |
| Kumar Neil | CEO and President | 2023-02-03 | SELL | 120,000 | $11.01 | $1321.2K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-01-05 | SELL | 61,040 | $7.67 | $468.2K |
| Kumar Neil | CEO and President | 2023-01-05 | SELL | 120,000 | $7.67 | $920.4K |
| Kumar Neil | CEO and President | 2022-12-21 | SELL | 200,000 | $8.26 | $1652K |
| Kumar Neil | CEO and President | 2022-11-17 | SELL | 34,640 | $9.4 | $325.6K |
| STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2022-11-17 | SELL | 19,678 | $9.4 | $185K |
| Dachille Douglas A. | Director | 2022-03-14 | BUY | 10,000 | $8.19 | $81.9K |
| Dachille Douglas A. | Director | 2022-01-05 | BUY | 10,000 | $16.37 | $163.7K |
| DANIELS RONALD J | Director | 2021-12-30 | BUY | 22,147 | $13.49 | $298.8K |
| Lo Andrew | Director | 2021-12-30 | BUY | 7,500 | $13.18 | $98.9K |
| SAUNDERS BRENT L | Director | 2021-12-29 | BUY | 17,600 | $14.48 | $254.8K |
| Valantine Hannah | Director | 2021-12-29 | BUY | 1,764 | $14.23 | $25.1K |
| Hassan Fred | Director | 2021-12-29 | BUY | 19,300 | $14.17 | $273.5K |
| MOMTAZEE JAMES C | Director | 2021-12-29 | BUY | 80,000 | $14.5 | $1160K |
| Valantine Hannah | Director | 2021-12-29 | BUY | 1,752 | $14.24 | $24.9K |
| DANIELS RONALD J | Director | 2021-12-28 | SELL | 11,745 | $12.8 | $150.3K |
| Valantine Hannah | Director | 2021-12-28 | BUY | 2,338 | $12.84 | $30K |
| SCHELLER RICHARD H | See Remarks | 2021-08-04 | SELL | 13,777 | $53.23 | $733.3K |
| Scott Randal W. | Director | 2021-02-17 | BUY | 16,000 | $62.5 | $1000K |
| STEPHENSON BRIAN C | See Remarks | 2021-02-17 | BUY | 8,000 | $62.5 | $500K |
| KKR Genetic Disorder L.P. | 10% Owner | 2021-02-17 | SELL | 3,450,000 | $60.47 | $208621.5K |
| Turtle Cameron | See Remarks | 2020-12-28 | SELL | 19,500 | $69.6 | $1357.2K |
| SCHELLER RICHARD H | See Remarks | 2020-12-21 | SELL | 60,401 | $65.32 | $3945.4K |
| SCHELLER RICHARD H | See Remarks | 2020-12-18 | SELL | 30,000 | $65.07 | $1952.1K |
| SCHELLER RICHARD H | See Remarks | 2020-12-15 | SELL | 31,443 | $60.38 | $1898.5K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-12-01 | SELL | 10,000 | $51.52 | $515.2K |
| Turtle Cameron | See Remarks | 2020-11-25 | SELL | 5,000 | $47.04 | $235.2K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-11-16 | SELL | 10,000 | $45 | $450K |
| MCCORMICK FRANK | Chairman of Oncology | 2020-11-13 | SELL | 100,000 | $42.76 | $4276K |
| Turtle Cameron | See Remarks | 2020-11-05 | SELL | 2,500 | $42.05 | $105.1K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-11-02 | SELL | 10,000 | $38.36 | $383.6K |
| HOMCY CHARLES J | Chairman of Pharmaceuticals | 2020-10-16 | SELL | 10,256 | $41 | $420.5K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-10-01 | SELL | 10,000 | $38.83 | $388.3K |
| HOMCY CHARLES J | Chairman of Pharmaceuticals | 2020-09-30 | SELL | 10,000 | $38 | $380K |
| Turtle Cameron | See Remarks | 2020-09-30 | SELL | 14,500 | $37.69 | $546.5K |
| HOMCY CHARLES J | Chairman of Pharmaceuticals | 2020-09-29 | SELL | 99,257 | $36.95 | $3667.5K |
| Turtle Cameron | See Remarks | 2020-09-18 | SELL | 2,500 | $42.01 | $105K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-09-18 | SELL | 10,000 | $40 | $400K |
| SCHELLER RICHARD H | See Remarks | 2020-09-16 | SELL | 25,000 | $37.5 | $937.5K |
| Turtle Cameron | See Remarks | 2020-09-15 | SELL | 2,500 | $37.06 | $92.7K |
| Turtle Cameron | See Remarks | 2020-09-11 | SELL | 2,000 | $35.02 | $70K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-09-01 | SELL | 10,000 | $28.73 | $287.3K |
| STEPHENSON BRIAN C | See Remarks | 2020-08-04 | SELL | 7,200 | $27.26 | $196.3K |
| Kumar Neil | CEO and President | 2020-08-04 | SELL | 80,000 | $27.23 | $2178.4K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-08-03 | SELL | 10,000 | $27.37 | $273.7K |
| Kumar Neil | CEO and President | 2020-07-02 | SELL | 143,470 | $30.75 | $4411.7K |
| STEPHENSON BRIAN C | See Remarks | 2020-07-01 | SELL | 10,800 | $30.93 | $334K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-07-01 | SELL | 10,000 | $30.97 | $309.7K |
| Turtle Cameron | See Remarks | 2020-06-30 | SELL | 10,000 | $32.66 | $326.6K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-06-08 | SELL | 606 | $30.01 | $18.2K |
| Kumar Neil | CEO and President | 2020-06-08 | SELL | 10,600 | $30.01 | $318.1K |
| STEPHENSON BRIAN C | See Remarks | 2020-06-08 | SELL | 2,000 | $30 | $60K |
| STEPHENSON BRIAN C | See Remarks | 2020-06-03 | SELL | 1,600 | $30.04 | $48.1K |
| Kumar Neil | CEO and President | 2020-06-03 | SELL | 5,930 | $30.05 | $178.2K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-06-03 | SELL | 784 | $30.04 | $23.6K |
| Kumar Neil | CEO and President | 2020-06-01 | SELL | 80,000 | $29.19 | $2335.2K |
| STEPHENSON BRIAN C | See Remarks | 2020-06-01 | SELL | 7,200 | $29.36 | $211.4K |
| HENDERSON MICHAEL THOMAS | Chief Business Officer | 2020-06-01 | SELL | 2,585 | $29.37 | $75.9K |
| KKR Genetic Disorder L.P. | 10% Owner | 2020-05-28 | SELL | 2,389,690 | $33.39 | $79791.7K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2020-05-05 | SELL | 1,460 | $30.47 | $44.5K |
| STEPHENSON BRIAN C | See Remarks | 2020-05-05 | SELL | 5,706 | $30.49 | $174K |
| Kumar Neil | CEO and President | 2020-05-05 | SELL | 79,600 | $31.02 | $2469.2K |
| Kumar Neil | CEO and President | 2020-05-04 | SELL | 80,400 | $29.4 | $2363.8K |
| STEPHENSON BRIAN C | See Remarks | 2020-05-04 | SELL | 8,694 | $29.37 | $255.3K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2020-05-04 | SELL | 3,905 | $29.52 | $115.3K |
| Turtle Cameron | See Remarks | 2020-04-27 | SELL | 2,000 | $32.01 | $64K |
| Turtle Cameron | See Remarks | 2020-04-08 | SELL | 8,000 | $27.04 | $216.3K |
| Kumar Neil | CEO and President | 2020-04-07 | SELL | 1,805 | $25.48 | $46K |
| Kumar Neil | CEO and President | 2020-04-03 | SELL | 300 | $25.09 | $7.5K |
| Kumar Neil | CEO and President | 2020-04-02 | SELL | 77,895 | $26.02 | $2026.8K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2020-04-01 | SELL | 2,585 | $26.94 | $69.6K |
| STEPHENSON BRIAN C | See Remarks | 2020-04-01 | SELL | 7,200 | $26.61 | $191.6K |
| Kumar Neil | CEO and President | 2020-03-03 | SELL | 120,000 | $32.28 | $3873.6K |
| STEPHENSON BRIAN C | See Remark | 2020-03-02 | SELL | 10,800 | $32.27 | $348.5K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2020-03-02 | SELL | 3,975 | $32.44 | $128.9K |
| Turtle Cameron | See Remarks | 2020-02-11 | SELL | 2,000 | $37.28 | $74.6K |
| HOMCY CHARLES J | Chairman of Pharmaceuticals | 2020-02-10 | SELL | 20,000 | $36 | $720K |
| Kumar Neil | CEO and President | 2020-02-05 | SELL | 30,893 | $34.87 | $1077.2K |
| Kumar Neil | See Remarks | 2020-02-04 | SELL | 89,107 | $34.7 | $3092K |
| STEPHENSON BRIAN C | See Remarks | 2020-02-04 | SELL | 10,800 | $34.73 | $375.1K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2020-02-03 | SELL | 3,975 | $34.9 | $138.7K |
| HOMCY CHARLES J | Chairman of Pharmaceuticals | 2020-01-14 | SELL | 10,000 | $35 | $350K |
| Turtle Cameron | See Remarks | 2020-01-08 | SELL | 12,807 | $34.37 | $440.2K |
| STEPHENSON BRIAN C | See Remarks | 2020-01-03 | SELL | 10,800 | $32.93 | $355.6K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2020-01-03 | SELL | 3,975 | $33.17 | $131.9K |
| Kumar Neil | See Remarks | 2020-01-03 | SELL | 120,000 | $32.52 | $3902.4K |
| MCCORMICK FRANK | Chairman of Oncology | 2019-12-30 | SELL | 100,000 | $37.55 | $3755K |
| KKR Genetic Disorder L.P. | 10% Owner | 2019-07-01 | BUY | 2,647,100 | $17 | $45000.7K |
| Sinha Uma | Chief Scientific Officer | 2019-07-01 | BUY | 14,000 | $17 | $238K |
| HENDERSON MICHAEL THOMAS | See Remarks | 2019-07-01 | BUY | 7,000 | $17 | $119K |
| STEPHENSON BRIAN C | See Remark | 2019-07-01 | BUY | 55,500 | $17 | $943.5K |
| VIKING GLOBAL INVESTORS LP | 10% Owner | 2019-06-27 | BUY | 4,705,900 | $17 | $80000.3K |
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | 2019-06-27 | BUY | 4,705,900 | $17 | $80000.3K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked